TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CARE

Carter Bank and Trust

Financial Services · Banks - Regional · listed since 2012

30.50$ -0.4% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

This light rates the company, not the share price. No documented substance finding is present: the Tier 1 capital ratio is 14.26 percent, total risk-based capital 15.51 percent, equity to assets 11.23 percent, the allowance covers nonperforming loans 146.88 percent, there are no Federal Home Loan Bank borrowings left, no going-concern doubt and no listing risk (all figures as of June 30, 2026). What is open is the decisive operating question, and it is open twice over. First, reported profit does not carry the business: of $114.7 million in the first half of 2026, $20.2 million remains adjusted, because roughly $100.9 million came from two sales that cannot be repeated. Second, it is unclear how durable the new 3.38 percent margin is: it draws on capital freed by the sold loan, on funding costs that fell 37 basis points, and on a securities repositioning that took a $12.5 million book loss to lift the yield on newly purchased paper from 2.28 to roughly 5.27 percent. Add a loan book that is roughly 71 percent commercial real estate and construction, and nonperforming loans that already climbed back from $24.0 million to $37.6 million. Expressly excluded from this color are price, valuation, float and volatility. Also excluded is the Altman-Z of -1.86 in our data: the formula is built for industrial and trading companies and carries no meaning at a deposit-funded bank. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Carter Bankshares is a $4.8 billion regional bank in Virginia that spent three years blocked by a single problem loan: $214 million at the end, 87.7 percent of all nonperforming loans and $91.2 million of forgone interest income. On March 26, 2026 it was sold for $289.5 million in cash — more than the $209.5 million of principal. Together with the sale of the insurance subsidiary that produced roughly $100.9 million of one-off gains in the first half and reported net income of $114.7 million against $20.2 million adjusted. What remains operationally is still an improvement: net interest margin from 2.80 to 3.38 percent, adjusted quarterly profit from $9.3 million to $11.6 million, Tier 1 capital from 10.87 to 14.26 percent. The open question is how much of that was the loan and how much the rate market — and the share price has already answered, up roughly 93 percent in twelve months. Not investment advice.

Credit quality & legacy exposure

The exposure that made up 87.7 percent of all nonperforming loans was sold on March 26, 2026, finally and without recourse: $289.5 million in cash for $209.5 million of principal. Nonperforming loans fell from $250.6 million (June 30, 2025) to $37.6 million (June 30, 2026), and their share of the loan book from 6.69 to 1.01 percent.

Capital position

As of June 30, 2026 the Tier 1 capital ratio stood at 14.26 percent, total risk-based capital at 15.51 percent, the leverage ratio at 11.65 percent and equity to assets at 11.23 percent — a year earlier those figures were 10.87, 12.12, 9.46 and 8.48 percent. Federal Home Loan Bank borrowings were repaid in full (December 31, 2025: $178.5 million).

Earnings quality

Of $114.7 million of first-half 2026 net income, $20.2 million remains on an adjusted basis. Roughly $100.9 million came from two one-off sales — the loan sale in the first quarter and the sale of the insurance subsidiary on May 1, 2026 — against a $12.5 million loss from repositioning the securities portfolio.

Margin & operating turn

The net interest margin rose from 2.80 percent (second quarter of 2025) through 3.07 to 3.38 percent (second quarter of 2026), with quarterly net interest income up from $32.4 million to $40.0 million. Adjusted quarterly profit grew from $9.3 million to $11.6 million and the adjusted efficiency ratio improved from 75.55 to 62.66 percent.

Concentration risk

As of March 31, 2026, of $3,728.5 million of loans, $2,127.9 million were commercial real estate and $513.6 million construction — roughly 71 percent, concentrated in Virginia and North Carolina. Nonperforming loans already rose again during the second quarter of 2026 from $24.0 million to $37.6 million, triggered by three loans of one relationship totaling $13.4 million.

Funding

As of June 30, 2026, $1,846.4 million of deposits were certificates of deposit; as of December 31, 2025, 71.7 percent of them matured within twelve months. That helped as rates fell — the cost of interest-bearing liabilities dropped from 3.06 to 2.74 percent during 2025 — but works the other way if rates rise.

Worth Noting

Carter Bankshares reached the research list through our in-house stock scanner "K/FCF ranking" (U.S. selection), measured July 27, 2026 on both brands: 545 U.S. hits, CARE at a K/FCF of 2.2229 in place 49 — identical on boersenlotse.de and tickerguard.com. The detail page shows only the 25 strongest hits, so CARE is not visible there; anyone wanting to find the name uses the screener and sets the P/FCF filter to its lowest band. These lists are recomputed daily.

The ratio is distorted twice over for this name and is therefore recomputed in the piece. First, free cash flow at a bank measures the interest margin before credit losses: released loan-loss provisions sit in operating cash flow, while the actual capital deployment — lending — sits in investing ($255.3 million in 2025, $61.4 million in the first quarter of 2026 alone). Second, the $289.5 million of loan sale proceeds also runs through operating activities as its own line, "Proceeds From the Transaction", because the loans were reclassified to held-for-sale beforehand (supplementary disclosure in the quarterly report: $209,484 thousand). Own calculation: market value of roughly $753.5 million divided by roughly $329 million of trailing four-quarter free cash flow gives 2.3; excluding the one-off, roughly 19; measured on fiscal 2025, roughly 24.

The Altman-Z of -1.86 in our data is expressly not used as a safety argument. In the Z" variant used here the thresholds are 1.1 (distress zone) and 2.6 (safe zone); the formula was, however, developed for industrial and trading companies and measures working capital, asset turnover and retained earnings against total assets — quantities that carry no economic meaning at a deposit-funded bank. Two other banks have already been removed from a scanner in this analysis series for the same reason. The assessment runs on bank metrics instead (as of 2026-06-30): Tier 1 capital ratio 14.26 percent, total risk-based capital 15.51 percent, leverage ratio 11.65 percent, equity to assets 11.23 percent, allowance for credit losses 1.48 percent of loans, nonperforming loans 1.01 percent, coverage 146.88 percent, net interest margin 3.38 percent.

Identity checked strictly, because the CARE ticker is ambiguous: the SEC ticker registry maps CARE to CIK 0001829576, and the cover page of the quarterly report for March 31, 2026 reads "CARTER BANKSHARES, INC.", Virginia, Commission File Number 001-39731, trading symbol CARE on the Nasdaq Global Select Market. No former names are recorded in the SEC entity data. Not to be confused: some data sets list the name "Carter Bank and Trust" — that is the subsidiary bank, not the listed holding company.

Price and valuation figures are dated anchors, not buy arguments: price $34.00 as of July 24, 2026, ratio data as of July 27, 2026. The market value of roughly $753.5 million is computed from 22,162,213 shares (balance sheet at June 30, 2026). After a roughly 93 percent gain over twelve months the stock sits at the highest level in company history, while the average analyst price target in the same data set is $28.

The most recent periodic report is the quarterly report 10-Q for March 31, 2026 (filed May 7, 2026). Filed after that, through the data date of July 27, 2026: current reports 8-K of May 1, 2026 (Item 8.01, completion of the insurance sale), May 1, 2026 (Items 7.01 and 9.01), May 29, 2026 (Item 5.07, annual meeting results), May 29, 2026 (Item 7.01), June 24, 2026 (Item 5.02, employment and change-of-control agreements), July 23, 2026 (Item 2.02, second-quarter 2026 results) and July 23, 2026 (Item 8.01, dividend), plus ownership filings (Schedule 13G) and insider reports (Form 4). All June 30, 2026 figures in this analysis come from the July 23, 2026 release; the corresponding quarterly report 10-Q had not been filed as of the data date and will carry those figures in reviewed form for the first time.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at CARE since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 17.00 $ to 35.70 $ · Last price: 30.50 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.7$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 23m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.7%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.5

Performance

Perf. 1M ?Price performance over the last month. 23.50%
Perf. 3M ?Price performance over the last 3 months. 46.20%
Perf. 6M ?Price performance over the last 6 months. 68.40%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 65.10%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -1.1%
Perf. 1Y ?Price performance over the last 12 months. 55.10%
Perf. 3Y ?Price performance over the last 3 years. 124.59%
Perf. 5Y ?Price performance over the last 5 years. 119.14%
Perf. 10Y ?Price performance over the last 10 years. 131.45%
Perf. Since Inception ?Price performance since the first available trading day (02/28/2007) — with a complete history, that is since the IPO. 287.88%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 32.30$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 32.40$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 25.80$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 37.7
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 24.7%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 27.5%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 13.7
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable.
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 0.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 12.0

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 100.0%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 44.9%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 23.9%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 2.7%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. -1.86
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 7 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 260.00%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY).
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 6.24%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. -21.80%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. -53.00%

Dividend

Dividend Yield ?Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year. 1.28%
Dividend Per Share (TTM) ?Sum of dividends paid per share over the last 12 months. 0.10$
Payout Ratio ?Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term. 12.5%
Years Without a Cut ?How many years in a row the dividend hasn't been cut — a measure of reliability. 0Years
Increase Streak ?How many years in a row the dividend has been raised — the gold standard for dividend payers. 0Years

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 89
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. Top 10% 96
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (57 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Banks - Regional

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Carter Bank and Trust CARE 0.7 0.0 100.0 6.2 55.1
Mizuho Financial Group Inc. MFG 135.7 17.4 0.0 100.0 46.7 10.4 70.5
HDFC Bank Limited HDB 116.5 15.8 0.0 100.0 33.3 24.3 -33.2
ICICI Bank Limited IBN 101.0 17.5 0.0 100.0 38.5 6.0 -12.0
U.S. Bancorp USB 92.6 12.8 0.0 100.0 37.8 0.4 26.3
PNC Financial Services Group Inc PNC 92.4 13.6 0.0 100.0 36.7 -7.0 17.6
Itau Unibanco Banco Holding SA ITUB 91.5 10.0 0.0 100.0 39.1 18.0 29.3
Deutsche Bank AG DB 73.5 10.3 0.0 100.0 33.4 -8.3 11.7
Nu Holdings Ltd NU 67.3 21.7 0.0 100.0 48.2 43.0 -13.1
Median of companies shown 92.4 14.7 0.0 100.0 38.2 6.2 17.6

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 147 $M 2016 · Operating income: 18 $M 2016 · Net income: 16 $M 2017 · Revenue: 144 $M 2017 · Operating income: -18 $M 2017 · Net income: -1 $M 2018 · Revenue: 158 $M 2018 · Operating income: 14 $M 2018 · Net income: 12 $M 2019 · Revenue: 168 $M 2019 · Operating income: 28 $M 2019 · Net income: 27 $M 2020 · Revenue: 164 $M 2020 · Operating income: -45 $M 2020 · Net income: -46 $M 2021 · Revenue: 156 $M 2021 · Operating income: 36 $M 2021 · Net income: 32 $M 2022 · Revenue: 179 $M 2022 · Operating income: 62 $M 2022 · Net income: 50 $M 2023 · Revenue: 212 $M 2023 · Operating income: 29 $M 2023 · Net income: 23 $M 2024 · Revenue: 240 $M 2024 · Operating income: 31 $M 2024 · Net income: 25 $M 2025 · Revenue: 255 $M 2025 · Operating income: 40 $M 2025 · Net income: 31 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 147 18 16 0.61 33 435 4,506
2017 144 -18 -1 -0.03 44 432 4,112
2018 158 14 12 0.45 49 436 4,040
2019 168 28 27 1.01 38 473 4,006
2020 164 -45 -46 -1.74 8 440 4,179
2021 156 36 32 1.20 78 408 4,134
2022 179 62 50 2.04 71 329 4,205
2023 212 29 23 1.01 47 351 4,513
2024 240 31 25 1.06 37 384 4,659
2025 255 40 31 1.40 40 420 4,852

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 60.9 $M Q4 2025: Q1 · 61.9 $M Q1 2025: Q2 · 61.7 $M Q2 2025: Q3 · 63.6 $M Q3 2025: Q4 · 64.5 $M Q4 2026: Q1 · 130.2 $M Q1

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.36 61 14.50 13.60 12 8
2025: Q1 0.39 53.40 62 6.10 14.50 6 5
2025: Q2 0.37 77.30 62 4.00 13.80 10 8
2025: Q3 0.24 -0.40 64 4.00 8.50 12 10
2025: Q4 0.39 8.90 65 5.90 13.10 12 7
2026: Q1 3.93 902.90 130 110.20 65.90 304 302
2026: Q2 1.31 254.10 -261 -263

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 21 of our scanner strategies — each hit links to the scanner.

Growth

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 3
Price Target (average) 35.08$
Distance to price 15.0% The price target sits 15.0% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 1
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 5.76 5.45 – 6.29 260 314.6% 3
12/31/2027 2.60 2.50 – 2.78 204 -54.9% 4

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly 0.3% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $58.8M
Market cap $684.0M
Free cash flow in year ten $60.4M
Terminal value as a share of market value 46.5%

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Künstliche Intelligenz kommt in den Berichten der Regionalbank ausschließlich als Risikohinweis vor; ein KI-Produkt, ein KI-Umsatz oder ein konkret benannter produktiver Einsatz wird nirgends belegt.

View the full file — quotes, sources, reviewed filings
„The Company, as well as or its third-party vendors, clients or counterparties may continue to develop or incorporate AI technologies into certain business processes, products, and services."

Das Unternehmen sowie seine externen Dienstleister, Kunden oder Vertragspartner könnten KI-Techniken weiterhin in bestimmte Geschäftsprozesse, Produkte und Dienstleistungen entwickeln oder einbinden.

10-K · 2026-03-05 · View SEC filing

„The development and use of Artificial Intelligence (“AI”) technologies present risks that could adversely affect the Company’s business, financial condition, and results of operations."

Die Entwicklung und Nutzung von Techniken der künstlichen Intelligenz („KI“) bringt Risiken mit sich, die sich nachteilig auf Geschäft, Finanzlage und Ertragslage des Unternehmens auswirken können.

10-K · 2026-03-05 · View SEC filing

Filings Reviewed: 10-K 2026-03-05 · 10-Q 2026-05-07 · 10-Q 2025-11-03 · 10-K 2025-03-07 · 8-K 2026-07-23

Rated on July 27, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

6 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years 12.4%
  • More than 10% revenue growth is expected for the coming year -21.8%
  • Share count grows by less than 3% a year -3.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 18.7%
  • Gross margin at 40% or higher and without meaningful erosion 61.7%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 310 m net cash
  • Operating cash flow covers the profits of the last three years 44 m
  • Return on capital at 15% or higher, or up versus two years ago 6.2%
  • Insiders hold at least 10% or are net buyers 2.3%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

5/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 6.3%
  • Exp. sales growth 3Y > 5% -10.5%
  • EBIT growth 10Y > 5% 9.5%
  • Exp. EBIT growth 3Y > 5% 36.4%
  • Net debt < 4x EBIT -7.8x
  • EBIT positive, 10Y straight 8
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 7.5%
  • ROCE > 15% 6.2%
  • Expected return > 10% 42.8%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 11, 2026 Midkiff Catharine L. Director Sell 1,000 31.25 31,250
Aug 4, 2026 Feldmann Gregory W Director Other 280 35.16 9,845
Jul 30, 2026 Langs Bradford N. PRESIDENT, CHIEF STRATEGY OFCR Sell 2,500 34.54 86,340
Jul 30, 2026 Bolton Robert M. Director Sell 1,500 34.60 51,900

View all insider transactions →

The company

About the Company

Carter Bankshares, Inc. ist die Bankholding der Carter Bank & Trust, die verschiedene Privat- und Geschäftskundenbankprodukte sowie Versicherungsdienstleistungen in den USA anbietet.

Employees
687
Headquarters
Martinsville, VA
Address
1300 Kings Mountain Road, 24112 Martinsville, United States
Phone
276 656 1776
IPO Date
08/27/2012
ISIN
US1461031064
Stock Split
1:1 on 11/23/2020

Management

Management
Name Title Birth Year
Litz H. Van Dyke CEO & Director 1964
Phyllis Q. Karavatakis Vice Chairman 1956
Wendy S. Bell Senior EVP & Chief Financial Officer 1964
Kimberly Dempsey Schaufenbuel Executive VP & Chief Human Resources Officer
A. Loran Adams Executive VP & Director of Regulatory Risk Management 1962
Jayson Philbeck Senior Vice President of Commercial Banking
Brad Wilson Senior VP & Commercial Market Executive
Joyce A. Parker Secretary
Misty Powell Assistant Vice President
Bill Hubble Vice President and Managing Officer of Blacksburg Office

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/17/2026 Carter Bankshares, Inc. (CARE): Other Events SEC ↗
  • 08/11/2026 Carter Bankshares, Inc. (CARE): Other Events SEC ↗
  • 07/27/2026 Carter Bankshares, Inc. (CARE): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 07/23/2026 Carter Bankshares, Inc. (CARE): Other Events; Financial Statements and Exhibits SEC ↗
  • 07/23/2026 Carter Bankshares, Inc. (CARE): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?